Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (1)
  • 2025 (1)
  • 2022 (4)
  • 2019 (2)
  • 2018 (9)

Subject

  • Drug Trafficking (34)
  • Take Back Day (26)
  • Outreach/Drug Prevention (23)
  • Prescription Drugs (23)
  • Public and Media Affairs - also see Congressional Affairs (17)
  • Synthetic drugs (15)
  • Fake Pills (13)
  • Arrests/Convictions - Major (11)
  • Major Law Enforcement Operation (11)
  • Press Conferences (11)
  • Diversion Division (10)
  • Fentanyl Awareness (10)
  • Pharmaceuticals/Pharmacists/Physicians (9)
  • Red Ribbon (9)
  • Guns/Weapons (8)
  • One Pill Can Kill (8)
  • Prevention/Education - DEA websites GSAD, JTT etc (8)
  • Money Laundering (7)
  • OCDETF/Task Force (5)
  • Seizures (Drugs/Property) (5)
  • Extraditions (4)
  • Fentanyl Free America (4)
  • Intergovernmental Affairs (4)
  • International/Foreign Operations (4)
  • Narcoterrorism (4)
  • Counterfeit Pills (3)
  • Critical Incident (3)
  • Gangs (3)
  • Campaigns (2)
  • Scam Calls (2)
  • Task Forces/Task Force Officers (2)
  • Terrorism (2)
  • Dark Web- Internet Trafficking (1)
  • HIDTA (1)
  • Intelligence Division - Intelligence Products (1)
  • Museum and Visitors Center (1)
  • Other (1)
  • Congressional Affairs (12)
  • Overdose (5)

Drug Name

  • Fentanyl (5)
  • Heroin (2)
  • Methamphetamine (2)
  • Synthetic Opioids (2)
  • Cocaine (1)
  • Marijuana (Cannabis) (1)
  • Marijuana Concentrates (1)
  • Oxycodone (1)

Field Division

  • Washington, DC (68)
  • New York (53)
  • San Diego (33)
  • St. Louis (28)
  • Atlanta (20)
  • Los Angeles (18)
  • El Paso (14)
  • Omaha (14)
  • Seattle (14)
  • Miami (12)
  • San Francisco (11)
  • Dallas (9)
  • Houston (7)
  • Chicago (5)
  • Louisville (5)
  • New England (3)
  • New Orleans (3)
  • Detroit (2)
  • New Jersey (2)
  • Philadelphia (2)
  • Phoenix (2)
  • Sede (17)
Clear All Results
17 Results - Showing 1 to 10
PRESS RELEASE

DEA Operation Meltdown Shuts Down Hundreds of Illegal Online Pharmacies

WASHINGTON – Today, the U.S. Drug Enforcement Administration, with the cooperation of the U.S. Attorney’s Office for the Eastern District of New York, announced the seizure of more than 200 website domains tied to an India-based transnational criminal organization (TCO) working within the United States and allegedly responsible for at...
PRESS RELEASE

DEA Releases 2025 National Drug Threat Assessment

WASHINGTON – The U.S. Drug Enforcement Administration today announced the release of the 2025 National Drug Threat Assessment (NDTA), DEA’s comprehensive review of the threats posed to the United States by deadly illicit drugs and the violent domestic and international drug trafficking organizations responsible for producing and trafficking the drugs...
PRESS RELEASE

DEA Dedicates September 11th Memorial

WASHINGTON - On Friday, September 9, 2022, the Drug Enforcement Administration dedicated a memorial at DEA Headquarters in Arlington, Virginia to DEA New York Drug Enforcement Task Force Officers who have lost their lives from illness or disease caused by their work at Ground Zero after the terrorist attacks of...
PRESS RELEASE

DEA Holds Inaugural Family Summit on the Overdose Epidemic

WASHINGTON – On June 14 and 15, DEA Administrator Anne Milgram hosted the first-ever DEA Family Summit on the Overdose Epidemic for families from across the country who have experienced the profound loss of a child due to a drug overdose or poisoning. Deputy Attorney General Lisa O. Monaco delivered...
PRESS RELEASE

President Biden Releases National Drug Control Strategy to Save Lives, Expand Treatment, and Disrupt Trafficking

WASHINGTON, D.C. – Today, President Joe Biden sent his Administration’s inaugural National Drug Control Strategy to Congress at a time when drug overdoses have reached a record high. The Strategy delivers on the call to action in President Biden’s Unity Agenda through a whole-of-government approach to beat the overdose epidemic...
PRESS RELEASE

DEA Warns of Increase in Mass-Overdose Events Involving Deadly Fentanyl

WASHINGTON – Today, the Drug Enforcement Administration sent a letter to federal, state, and local law enforcement partners warning of a nationwide spike in fentanyl-related mass-overdose events. Administrator Anne Milgram outlined the current threat and offered DEA support to law enforcement officers responding to these tragic incidents. “Fentanyl is killing...
PRESS RELEASE

DEA announces enhanced tool for registered drug manufacturers and distributors to combat opioid crisis

WASHINGTON – The Drug Enforcement Administration today announced the launch of an enhanced system to help more than 1,500 registered drug manufacturers and distributors nationwide more effectively identify potential illicit drug diversion and combat the opioid epidemic. On Oct. 24, 2018, President Trump signed into law the “Substance Use–Disorder Prevention...
PRESS RELEASE

Manhattan U.S. Attorney announces extradition of OFAC- sanctioned Afghan man for Narco-Terrorism offenses

NEW YORK - Christopher Tersigni, Special Agent in Charge of the United States Drug Enforcement Administration Special Operations Division and Geoffrey S. Berman, the United States Attorney for the Southern District of New York, announced today the extradition of Haji Abdul Satar Abdul Manaf, aka “Haji Abdul Sattar Barakzai,” for...
PRESS RELEASE

DEA releases 2018 National Drug Threat Assessment

WASHINGTON – DEA Acting Administrator Uttam Dhillon today announced results of the 2018 National Drug Threat Assessment, which outlines the threats posed to the United States by domestic and international drug trafficking and the abuse of illicit drugs. “This report underscores the scope and magnitude of the ongoing opioid crisis...
PRESS RELEASE

DEA acts against dangerous, deadly designer synthetic drug linked to 151 overdose deaths since 2015

WASHINGTON – The Drug Enforcement Administration today announced action against a dangerous designer synthetic cathinone linked to 151 overdose deaths in the United States between 2015 and 2018. Published in today’s Federal Register, DEA’s action puts N-Ethylpentylone into Schedule I of the Controlled Substances Act. Schedule I substances refer to...

Paginación

  • Current page 1
  • Page 2
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster